Study of ENP-501 in Peanut-Allergic and Non-Allergic Participants
NCT07117669
This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
This is a Phase 1/2 study to evaluate the safety and clinical activity of ENP-501 in non-peanut allergic (NPA) healthy participants and participants with an established peanut allergy (PA)
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Peanut Allergy
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Phase 1/2
- Ages
- 14 to 50 years
- Sex
- All
- Healthy volunteers
- Accepted
- Sponsor
- N-Fold, LLC
- Last updated on ClinicalTrials.gov
- April 24, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Colorado · 1
- Research Site 001 · Aurora, CO
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.